Order Breast
Cancer
IndexOrder Breast Cancer IndexOrder Breast Cancer Index

The Predictive Power Of Breast Cancer Index®

Breast Cancer Index Has Demonstrated Consistent Predictive Evidence Across 5 Studies and Over 4,500 Patients1-5

Data supports comprehensive utility in pre- and post-menopausal women with various treatment histories and clinical features

Studies included patients with node-positive and node-negative disease, encompassing tumor sizes T1-3 and grades 1-3.

For patients disease-free at year 5

The HOXB13/IL17BR (BCI) ratio remains the only biomarker that has demonstrated significant treatment interaction for prediction of extended endocrine therapy benefit, earning guideline inclusion earlier this year.”

— Mark Pegram, MD

Back to Top